Stay updated with breaking news from Case Series. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
-- FDA has cleared Caribou’s IND application for CB-010 in lupus nephritis and extrarenal lupus; GALLOP Phase 1 clinical trial expected to initiate by YE 2024 -- -- Driven by encouraging initial...
<p>Researchers have developed a new method for triggering and imaging seizures in epilepsy patients, offering physicians the ability to collect real-time data to tailor epilepsy surgery. In contrast to previous practice, where physicians from neurology and nuclear medicine had to wait for hours to days in hopes of capturing the onset of a seizure, the new method is convenient, spares resources, and is clinically feasible. This research was published in the March issue of <em>The Journal of Nuclear Medicine</em>.</p>
“You didn’t give your daughter the MMR, did you?” The tone of voice is the first giveaway. Mild incredulity, but not so mild that you would fail to notice it. They need you to notice it so that you can have The Conversation. So that you can be converted. Because like the evangelists standing at your door, brandishing a leaflet, this breed of anti-vaxxer wants to witness the epiphany.
<p>The first published evidence from humans that semaglutide specifically reduces the symptoms of Alcohol Use Disorder (AUD) has been published in <em>The Journal of Clinical Psychiatry.</em></p>